Skip to main content

Latest stock market podcasts

From the helm: Proteomics International (ASX:PIQ), Dr. Richard Lipscombe, Managing Director

Bell Direct
July 7, 2025

In this episode of From the helm, Bell Financial Group’s Grady Wulff speaks with Proteomics International Laboratories (ASX: PIQ) CEO, Dr. Richard Lipscombe, about the company’s ground breaking work in predictive diagnostics and the global opportunity for its world-first blood tests.

In this video, Dr. Lipscombe covers:
·      (0:47): An overview of PIQ and its FY26 goals
·      (1:38): The significance of three world-first blood tests
·      (5:26): The global addressable markets for these conditions
·      (6:25): Clinical trial progress and commercialisation roadmap
·      (8:14): How the diagnostic tests work and deliver value to patients
·      (9:16): Commercialisation strategy across key regions
·      (11:23): Additional assets in the PIQ pipeline
·      (12:36): What investors can expect over the next 12 months

Note: This interview was recorded on 3 July 2025.

Morning Bell 30 June

Bell Direct
June 30, 2020

Morning Bell 29 June

Bell Direct
June 29, 2020

Monthly Wrap June 2020

Jessica Amir
June 26, 2020

Morning 26 June

Bell Direct
June 26, 2020

Morning Bell 25 June

Bell Direct
June 25, 2020

Morning Bell 24 June

Bell Direct
June 24, 2020

Morning Bell 23 June

Bell Direct
June 23, 2020

Morning Bell 22 June

Bell Direct
June 22, 2020

Weekly Wrap 19 June

Bell Direct
June 19, 2020

Morning Bell 19 June

Bell Direct
June 19, 2020

Morning Bell 18 June

Bell Direct
June 18, 2020

Morning Bell 17 June

Bell Direct
June 17, 2020